ARCHIVES

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 40 | October 20, 1995

Download PDF Visit The Full Archive

Related Articles

NCI Ponders Options for Implementing NCAB Changes In Organ Site Program

June 4, 1982

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

In Brief: Jensen, Selikoff Receive ACS National Awards; CCIRC Schedules Mini-Symposium

October 22, 1976

I-ELCAP Results Internally Inconsistent, Peter Bach Writes

June 24, 2011

NIH Director: NCI’s Special Authorities “More Of A Negative Than A Positive”

June 11, 2010

U of Pittsburgh Wins NCI Grant To Include End-of-Life Issues In Med. School Curriculum.

July 6, 2001